NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/22/2022
Back to search
Official data from USPTO
AFFIVANT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
AFFIVANT
ST13
US500000090850396Class
5, 42, 44
Filing
90850396
Registration
6904414
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
11/22/2022
Trademark type
Word
Nice classes
5, 42, 44
Filing date
07/27/2021
Registration date
11/22/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/22/2022
Last transaction
11/22/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
99
Owner location
Basel, CH
Examiner
BELL, JUSTIN
Law office
M30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Affivant Sciences GmbH
Representatives
Allison Strickland Ricketts FROSS ZELNICK LEHRMAN & ZISSU, P.C.
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for human usefor the prevention and treatment of oncologicalneurological and immunological diseases and disorders; pharmaceutical preparations for human use comprising cell-based therapies for the treatment of oncologicalneurological and immunological diseases and disorders; biologic preparations for medical and therapeutic purposesfor the prevention and treatment of oncologicalneurological and immunological diseases and disorders; pharmaceutical and biological preparations for prevention and treatment of oncologicalneurological and immunological diseases and disorders; pharmaceutical preparations comprising monoclonal antibodies and bispecific antibodies for the treatment of oncologicalneurological and immunological diseases and disorders; pharmaceutical preparations comprising monoclonal antibodies and bispecific antibodies for the treatment of oncologicalneurological and immunological diseases and disorders
Class 42
Scientific and technological servicesmedical researchscientific research and analysis in the fields of pharmaceutical and biomedicine and research and design relating thereto; pharmaceutical and biomedical research services; research in the field of pharmaceutical and biologic therapeutic preparations; pharmaceutical research and development; providing scientific research information in the field of pharmaceuticals and biomedicine
Class 44
Providing health and medical information; providing information relating to the diagnosticprophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseasesdisorders and conditions
Publications
History of USPTO decisions and trademark events.
20 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
11/22/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/06/2022
PUBO
PUBLISHED FOR OPPOSITION
09/06/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/17/2022
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
08/03/2022
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
07/29/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/25/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/21/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/21/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/21/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/26/2022
GNRT
NON-FINAL ACTION E-MAILED
04/26/2022
CNRT
NON-FINAL ACTION WRITTEN
04/26/2022
DOCK
ASSIGNED TO EXAMINER
04/22/2022
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
10/04/2021
ALIE
ASSIGNED TO LIE
10/04/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/24/2021
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
08/04/2021
NWAP
NEW APPLICATION ENTERED
07/30/2021
Continuous trademark protection
Get notified about every new filing that threatens AFFIVANT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.